GSK2830371 is primarily utilized in biochemical research as a potent and selective inhibitor of WIP1 phosphatase. Its application is crucial in studying cellular signaling pathways, particularly those involving p53 and its role in tumor suppression. Researchers use this compound to investigate the mechanisms of DNA damage response and cellular stress, providing insights into cancer biology and potential therapeutic strategies. Additionally, GSK2830371 aids in exploring the regulation of cell cycle progression and apoptosis, contributing to the development of targeted cancer treatments. Its specificity makes it a valuable tool in preclinical studies aimed at understanding and modulating phosphatase activity in various disease models.